The Neurobiology of Autism
暂无分享,去创建一个
[1] S. Puglisi‐Allegra,et al. Clinical, Morphological, and Biochemical Correlates of Head Circumference in Autism , 2007, Biological Psychiatry.
[2] Pat Levitt,et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder , 2007, Annals of neurology.
[3] Stephen T Warren,et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. , 2007, Human molecular genetics.
[4] S. Tonegawa,et al. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice , 2007, Proceedings of the National Academy of Sciences.
[5] N. Minshew,et al. The new neurobiology of autism: cortex, connectivity, and neuronal organization. , 2007, Archives of neurology.
[6] Elizabeth Garrett-Mayer,et al. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. , 2007, Archives of general psychiatry.
[7] Christopher Gillberg,et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[8] Joseph Piven,et al. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. , 2007, Archives of general psychiatry.
[9] A. Represa,et al. Neurotransmitters and Brain Maturation: Early Paracrine Actions of GABA and Glutamate Modulate Neuronal Migration , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[10] V. Meiner,et al. Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. , 2007, Journal of intellectual disability research : JIDR.
[11] J. Hensler,et al. Serotonin transporter function, but not expression, is dependent on brain‐derived neurotrophic factor (BDNF): in vivo studies in BDNF‐deficient mice , 2007, Journal of neurochemistry.
[12] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[13] T. Furuichi,et al. Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants , 2007, BMC Neuroscience.
[14] Mao Sheng Yang,et al. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence , 2007, International Journal of Developmental Neuroscience.
[15] S. Ishiura,et al. Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations. , 2007, Biochemical and biophysical research communications.
[16] Mira Park,et al. Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios , 2007, Brain Research.
[17] Julie Daniels,et al. The epidemiology of autism spectrum disorders. , 2007, Annual review of public health.
[18] Eric Butter,et al. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly , 2007, American journal of medical genetics. Part A.
[19] S. Puglisi‐Allegra,et al. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1 , 2007, BMC Medical Genetics.
[20] S. Itohara,et al. Impaired Cerebellar Development and Function in Mice Lacking CAPS2, a Protein Involved in Neurotrophin Release , 2007, The Journal of Neuroscience.
[21] L. Lee,et al. Maternal antibrain antibodies in autism , 2007, Brain, Behavior, and Immunity.
[22] Thomas Bourgeron,et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.
[23] J. Hutsler,et al. Histological and Magnetic Resonance Imaging Assessment of Cortical Layering and Thickness in Autism Spectrum Disorders , 2007, Biological Psychiatry.
[24] D. Geschwind,et al. Autism spectrum disorders: developmental disconnection syndromes , 2007, Current Opinion in Neurobiology.
[25] T. Soderling,et al. Regulatory mechanisms of AMPA receptors in synaptic plasticity , 2007, Nature Reviews Neuroscience.
[26] Astrid M. Vicente,et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels , 2007, Human Genetics.
[27] F. Barale,et al. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE–RAGE axis in autism , 2006, Neuroscience Letters.
[28] Stepan Melnyk,et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[29] G. Dawson,et al. Evidence for multiple loci from a genome scan of autism kindreds , 2006, Molecular Psychiatry.
[30] Charles E. Schwartz,et al. High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.
[31] Pat Levitt,et al. A genetic variant that disrupts MET transcription is associated with autism , 2006, Proceedings of the National Academy of Sciences.
[32] A. McAllister,et al. The Dynamic Distribution of TrkB Receptors before, during, and after Synapse Formation between Cortical Neurons , 2006, The Journal of Neuroscience.
[33] Thomas J. Eluvathingal,et al. Cerebellar Lesions in Tuberous Sclerosis Complex , 2006, Journal of child neurology.
[34] L. Boccone,et al. Bannayan–Riley–Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation , 2006, American journal of medical genetics. Part A.
[35] E. Hatchwell,et al. Autism and environmental genomics. , 2006, Neurotoxicology.
[36] C. Bramham,et al. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. , 2006, Current opinion in drug discovery & development.
[37] J. Sutcliffe,et al. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility , 2006, European Journal of Human Genetics.
[38] A. Braun,et al. Neuro-immune interaction in allergic asthma: role of neurotrophins. , 2006, Biochemical Society transactions.
[39] A. Chauhan,et al. Oxidative stress in autism. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.
[40] A. Braun,et al. The contribution of neurotrophins to the pathogenesis of allergic asthma. , 2006, Biochemical Society transactions.
[41] David G. Amaral,et al. Stereological Analysis of Amygdala Neuron Number in Autism , 2006, The Journal of Neuroscience.
[42] C. Eberhart,et al. Brief Report: S6 Ribosomal Protein Phosphorylation in Autistic Frontal Cortex and Cerebellum: a Tissue Array Analysis , 2006, Journal of autism and developmental disorders.
[43] P. Ashwood,et al. The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.
[44] T. Bourgeron,et al. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues , 2006, Trends in Neurosciences.
[45] E. Cook,et al. ITGB3 shows genetic and expression interaction with SLC6A4 , 2006, Human Genetics.
[46] Wei Zhang,et al. Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.
[47] R. Kerwin,et al. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. , 2006, The American journal of psychiatry.
[48] L. E. Arnold,et al. Neurochemical correlates of autistic disorder: a review of the literature. , 2006, Research in developmental disabilities.
[49] W. McMahon,et al. Hyperserotoninemia and Altered Immunity in Autism , 2006, Journal of autism and developmental disorders.
[50] E. Bacchelli,et al. Absence of coding mutations in the X‐linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[51] Mijna Hadders-Algra,et al. Ontogeny of the human central nervous system: what is happening when? , 2006, Early human development.
[52] C. McDougle,et al. The use of selective serotonin reuptake inhibitors in autism and related disorders. , 2006, Journal of child and adolescent psychopharmacology.
[53] A. Kolevzon,et al. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. , 2006, The Journal of clinical psychiatry.
[54] Laurent Groc,et al. AMPA signalling in nascent glutamatergic synapses: there and not there! , 2006, Trends in Neurosciences.
[55] Jareen Meinzen-Derr,et al. Elevated cytokine levels in children with autism spectrum disorder , 2006, Journal of Neuroimmunology.
[56] R. Neuman,et al. Brain-Derived Neurotrophic Factor and Autoantibodies to Neural Antigens in Sera of Children with Autistic Spectrum Disorders, Landau-Kleffner Syndrome, and Epilepsy , 2006, Biological Psychiatry.
[57] Michael Frotscher,et al. Recent progress in understanding the role of Reelin in radial neuronal migration, with specific emphasis on the dentate gyrus , 2006, The European journal of neuroscience.
[58] Janet K. Kern,et al. Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.
[59] M. Hollmann,et al. Functional Significance of the Kainate Receptor GluR6(M836I) Mutation that is Linked to Autism , 2006, Cellular Physiology and Biochemistry.
[60] C. Hoogenraad,et al. Control of Dendritic Arborization by the Phosphoinositide-3′-Kinase–Akt–Mammalian Target of Rapamycin Pathway , 2005, The Journal of Neuroscience.
[61] G. Dawson,et al. Autism and the serotonin transporter: the long and short of it , 2005, Molecular Psychiatry.
[62] L. Peltonen,et al. Analysis of four neuroligin genes as candidates for autism , 2005, European Journal of Human Genetics.
[63] M. Grider,et al. In situ expression of brain‐derived neurotrophic factor or neurotrophin‐3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion , 2005, Journal of neuroscience research.
[64] D. Amaral,et al. Stereological estimation of the number of neurons in the human amygdaloid complex , 2005, The Journal of comparative neurology.
[65] J. Miyazaki,et al. A Novel Role of Hepatocyte Growth Factor as an Immune Regulator through Suppressing Dendritic Cell Function1 , 2005, The Journal of Immunology.
[66] M. Herbert,et al. Large Brains in Autism: The Challenge of Pervasive Abnormality , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[67] Pat Levitt,et al. Disruption of Interneuron Development , 2005, Epilepsia.
[68] Z. Talebizadeh,et al. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism , 2005, Journal of Medical Genetics.
[69] C. Deutsch,et al. Macrocephaly and the control of brain growth in autistic disorders , 2005, Progress in Neurobiology.
[70] E R Martin,et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. , 2005, American journal of human genetics.
[71] J. Sutcliffe,et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. , 2005, American journal of human genetics.
[72] T. Südhof,et al. Dissection of Synapse Induction by Neuroligins , 2005, Journal of Biological Chemistry.
[73] J. Sutcliffe,et al. Analysis of the RELN gene as a genetic risk factor for autism , 2005, Molecular Psychiatry.
[74] Daniel E Weeks,et al. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. , 2005, American journal of human genetics.
[75] A. Battaglia,et al. Possible association between autism and variants in the brain‐expressed tryptophan hydroxylase gene (TPH2) , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[76] Abraham Weizman,et al. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia , 2005, European Neuropsychopharmacology.
[77] T. Panagiotaropoulos,et al. Cellular mechanisms underlying the effects of an early experience on cognitive abilities and affective states , 2005, Annals of general psychiatry.
[78] David A. Pearce,et al. Reelin signaling is impaired in autism , 2005, Biological Psychiatry.
[79] C Eng,et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations , 2005, Journal of Medical Genetics.
[80] Otto Muzik,et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism , 2005, International Journal of Developmental Neuroscience.
[81] Eric Courchesne,et al. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity , 2005, International Journal of Developmental Neuroscience.
[82] E. Courchesne,et al. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection , 2005, Current Opinion in Neurobiology.
[83] N. Craddock,et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients , 2005, Molecular Psychiatry.
[84] E. Deneris,et al. Making and breaking serotonin neurons and autism , 2005, International Journal of Developmental Neuroscience.
[85] Husseini Manji,et al. Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. , 2005, The American journal of psychiatry.
[86] I. Smith,et al. Behavioral profiles and symptoms of autism in CHARGE syndrome: Preliminary Canadian epidemiological data , 2005, American journal of medical genetics. Part A.
[87] E. Hollander,et al. A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism , 2005, Neuropsychopharmacology.
[88] Marcel Adam Just,et al. Functional connectivity in an fMRI working memory task in high-functioning autism , 2005, NeuroImage.
[89] Cathleen K. Yoshida,et al. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. , 2005, Archives of pediatrics & adolescent medicine.
[90] Laurent Mottron,et al. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[91] A. Zimmerman,et al. Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.
[92] A. Zimmerman,et al. Immunity, neuroglia and neuroinflammation in autism , 2005, International review of psychiatry.
[93] Ann Marie Craig,et al. Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins , 2004, Cell.
[94] David W Gaylor,et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.
[95] Dai Zhang,et al. Family‐based association study between autism and glutamate receptor 6 gene in Chinese Han trios , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[96] W. Brown,et al. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.
[97] Nils Brose,et al. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin , 2004, Neuropharmacology.
[98] Stuart Maudsley,et al. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.
[99] Yu Tian Wang,et al. A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[100] S. Eichner,et al. Treating Functional Impairment of Autism with Selective Serotonin-Reuptake Inhibitors , 2004, The Annals of pharmacotherapy.
[101] E. Alleva,et al. Epigenetic control of neurobehavioural plasticity: the role of neurotrophins , 2004, Behavioural pharmacology.
[102] B. Barres,et al. Role for glia in synaptogenesis , 2004, Glia.
[103] S. Scherer,et al. Mutation screening of X‐chromosomal neuroligin genes: No mutations in 196 autism probands , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[104] A. Davies,et al. HGF regulates the development of cortical pyramidal dendrites , 2004, Development.
[105] R. Sakuta,et al. Serum neurotrophin concentrations in autism and mental retardation: a pilot study , 2004, Brain and Development.
[106] Elizabeth Redcay,et al. The autistic brain: birth through adulthood , 2004, Current opinion in neurology.
[107] S. Schwartz,et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. , 2004, Pediatrics.
[108] S. Connell,et al. Sex-specific development of cortical monoamine levels in mouse. , 2004, Brain research. Developmental brain research.
[109] D. Amaral,et al. The Amygdala Is Enlarged in Children But Not Adolescents with Autism; the Hippocampus Is Enlarged at All Ages , 2004, The Journal of Neuroscience.
[110] Pat Levitt,et al. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders , 2004, Trends in Neurosciences.
[111] S. Zoroglu,et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.
[112] Igor Tsigelny,et al. The Arg451Cys-Neuroligin-3 Mutation Associated with Autism Reveals a Defect in Protein Processing , 2004, The Journal of Neuroscience.
[113] E. Courchesne. Brain development in autism: early overgrowth followed by premature arrest of growth. , 2004, Mental retardation and developmental disabilities research reviews.
[114] C Eng,et al. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome , 2004, Journal of Medical Genetics.
[115] G. Dawson,et al. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[116] David A. Ziegler,et al. Localization of white matter volume increase in autism and developmental language disorder , 2004, Annals of neurology.
[117] Albert David,et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. , 2004, American journal of human genetics.
[118] Alessandro Quattrone,et al. Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism , 2004, Biological Psychiatry.
[119] L. Lotspeich,et al. White matter structure in autism: preliminary evidence from diffusion tensor imaging , 2004, Biological Psychiatry.
[120] W. Salinger,et al. Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. , 2003, Behavioral neuroscience.
[121] D. Buxhoeveden,et al. Disruption in the Inhibitory Architecture of the Cell Minicolumn: Implications for Autisim , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[122] H. Zoghbi. Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? , 2003, Science.
[123] R. Riikonen. Neurotrophic Factors in the Pathogenesis of Rett Syndrome , 2003, Journal of child neurology.
[124] S. Klauck,et al. Analysis of reelin as a candidate gene for autism , 2003, Molecular Psychiatry.
[125] J. Bolz,et al. Differential Regulation of Thalamic and Cortical Axonal Growth by Hepatocyte Growth Factor/Scatter Factor , 2003, Developmental Neuroscience.
[126] J. Gilmore,et al. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal–fetal unit of the rat , 2003, Journal of Neuroimmunology.
[127] Thomas Bourgeron,et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.
[128] David A. Ziegler,et al. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. , 2003, Brain : a journal of neurology.
[129] F. Serajee,et al. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism , 2003, Journal of medical genetics.
[130] Stephen W Scherer,et al. Cloning and characterization of human CADPS and CADPS2, new members of the Ca2+-dependent activator for secretion protein family. , 2003, Genomics.
[131] O. Yorbik,et al. Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[132] R. Fields,et al. New insights into neuron-glia communication. , 2002, Science.
[133] T. Takano,et al. Beyond the role of glutamate as a neurotransmitter , 2002, Nature Reviews Neuroscience.
[134] Woong Sun,et al. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. , 2002, Brain research. Molecular brain research.
[135] P. Bolton,et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. , 2002, Brain : a journal of neurology.
[136] A. Baghdadli,et al. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. , 2002, L'Encephale.
[137] M. Eric Gershwin,et al. Genetic and Immunologic Considerations in Autism , 2002, Neurobiology of Disease.
[138] G. Dawson,et al. Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay. , 2002, Child development.
[139] Andrew E. Switala,et al. Minicolumnar pathology in autism , 2002, Neurology.
[140] P. Burger,et al. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease , 2001, Nature Genetics.
[141] T. Kemper,et al. Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.
[142] J. Pevsner,et al. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism , 2001, Neurology.
[143] H. Neumann. Control of glial immune function by neurons , 2001, Glia.
[144] F. Aloisi. Immune function of microglia , 2001, Glia.
[145] H. Lassmann,et al. Inflammation in the nervous system: The human perspective , 2001, Glia.
[146] E. Benveniste,et al. Immune function of astrocytes , 2001, Glia.
[147] J. Antel,et al. Glial cell influence on the human blood‐brain barrier , 2001, Glia.
[148] R. Rothermel,et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction , 2001, Neurology.
[149] N. Minshew. What are neuropeptides and neurotrophins and why are they important in autism? , 2001, Journal of autism and developmental disorders.
[150] L. Hoefsloot,et al. PTEN mutation in a family with Cowden syndrome and autism. , 2001, American journal of medical genetics.
[151] A. McAllister. Neurotrophins and neuronal differentiation in the central nervous system , 2001, Cellular and Molecular Life Sciences CMLS.
[152] Cheuk Y. Tang,et al. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. , 2001, The international journal of neuropsychopharmacology.
[153] J. Dambrosia,et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation , 2001, Annals of neurology.
[154] Axel Benner,et al. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. , 2001, Human molecular genetics.
[155] P. Levitt,et al. Hepatocyte Growth Factor/Scatter Factor Is a Motogen for Interneurons Migrating from the Ventral to Dorsal Telencephalon , 2001, Neuron.
[156] T. Wassink,et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder , 2001, Molecular Psychiatry.
[157] R. Pullarkat,et al. Proteomic Approach for the Elucidation of Biological Defects in Autism , 2001, Journal of autism and developmental disorders.
[158] Dennis L. Murphy,et al. Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.
[159] Minshew Nj. Articles related to high-functioning individuals with autism or Asperger disorder. , 2001 .
[160] E. Castrén,et al. Expression of c‐Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D‐expressing neurons , 2000, The European journal of neuroscience.
[161] P. Schirmacher,et al. Hepatocyte growth factor-stimulated invasiveness of monocytes. , 2000, Blood.
[162] B. Meldrum,et al. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. , 2000, The Journal of nutrition.
[163] S. Puglisi‐Allegra,et al. Serotonin Depletion and Barrel Cortex Development : Impact of Growth Impairment vs . Serotonin Effects on Thalamocortical Endings , 2022 .
[164] David R. Kaplan,et al. BDNF Promotes the Regenerative Sprouting, But Not Survival, of Injured Serotonergic Axons in the Adult Rat Brain , 2000, The Journal of Neuroscience.
[165] C. Wihler,et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[166] F. Hallböök. Evolution of the vertebrate neurotrophin and Trk receptor gene families , 1999, Current Opinion in Neurobiology.
[167] I. Rapin,et al. The autistic-spectrum disorders. , 1999, The New England journal of medicine.
[168] T. Zetterström,et al. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain , 1999, Neuropharmacology.
[169] Paul Law,et al. Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism , 1999, Journal of child neurology.
[170] E. Fombonne,et al. Microcephaly and Macrocephaly in Autism , 1999, Journal of autism and developmental disorders.
[171] R. Rothermel,et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children , 1999, Annals of neurology.
[172] R. Duman,et al. Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus , 1999, Neuroscience Letters.
[173] C. Eng,et al. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. , 1998, American journal of medical genetics.
[174] C. Birchmeier,et al. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.
[175] G. Delong,et al. Effects of fluoxetine treatment in young children with idiopathic autism , 1998, Developmental medicine and child neurology.
[176] P. Thuras,et al. Fluoxetine in Treatment of Adolescent Patients with Autism: A Longitudinal Open Trial , 1998, Journal of autism and developmental disorders.
[177] D. Cohen,et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.
[178] F. Sallee,et al. Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.
[179] T. Kemper,et al. Neuropathology of infantile autism. , 1998, Journal of neuropathology and experimental neurology.
[180] A. Bailey,et al. A clinicopathological study of autism. , 1998, Brain : a journal of neurology.
[181] M. Cuccaro,et al. Autism and maternally derived aberrations of chromosome 15q. , 1998, American journal of medical genetics.
[182] P. Schirmacher,et al. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. , 1997, Blood.
[183] P. Whitaker-Azmitia,et al. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits , 1997, Brain Research.
[184] N J Cox,et al. Evidence of linkage between the serotonin transporter and autistic disorder , 1997, Molecular Psychiatry.
[185] V. Mountcastle. The columnar organization of the neocortex. , 1997, Brain : a journal of neurology.
[186] J. Haring,et al. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. , 1997, Brain research. Developmental brain research.
[187] Paul D Griffiths,et al. Association of tuberous sclerosis of temporal lobes with autism and atypical autism , 1997, The Lancet.
[188] C. Zeanah,et al. The clinical assessment of attachment in children under five. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[189] S. Folstein,et al. Macrocephaly in children and adults with autism. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[190] C. McDougle,et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. , 1996, Archives of general psychiatry.
[191] B. Leventhal,et al. The serotonin system in autism. , 1996, Current opinion in pediatrics.
[192] J. Hornung,et al. Laminar development of the mouse barrel cortex: effects of neurotoxins against monoamines , 1996, Experimental Brain Research.
[193] G. Lyon,et al. NEUROPATHOLOGICAL STUDY OF A CASE OF AUTISTIC SYNDROME WITH SEVERE MENTAL RETARDATION , 1996, Developmental medicine and child neurology.
[194] T. Kemper,et al. Hippocampus in autism: a Golgi analysis , 1995, Acta Neuropathologica.
[195] C. Bennett-Clarke,et al. Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[196] K. Grotemeyer,et al. Serotonin and amino acid content in platelets of autistic children , 1993, Acta psychiatrica Scandinavica.
[197] B. Leventhal,et al. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.
[198] S. Jhaveri,et al. A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. , 1991, Cerebral cortex.
[199] M. Ghaziuddin,et al. Fluoxetine in autism with depression. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.
[200] B. Leventhal,et al. Autism and tuberous sclerosis , 1991, Journal of autism and developmental disorders.
[201] J. Rubin,et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.
[202] M. Jacquin,et al. Development and lesion induced reorganization of the cortical representation of the rat's body surface as revealed by immunocytochemistry for serotonin , 1990, The Journal of comparative neurology.
[203] J. Coyle,et al. Transient postnatal elevation of serotonin levels in mouse neocortex. , 1988, Brain research.
[204] S. Snyder,et al. Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[205] T. Maeda,et al. Early development of serotonin neuron in the rat brain as studied by immunohistochemistry combined with tryptophan administration , 1986, Brain and Development.
[206] J. Buitelaar,et al. Medication treatment in subjects with autistic spectrum disorders , 2009, European Child & Adolescent Psychiatry.
[207] P. Hazell. Drug therapy for attention‐deficit/hyperactivity disorder‐like symptoms in autistic disorder , 2007, Journal of paediatrics and child health.
[208] Thomas Bourgeron,et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.
[209] F. Serajee,et al. Association of Reelin gene polymorphisms with autism. , 2006, Genomics.
[210] G. Blatt. GABAergic cerebellar system in autism: a neuropathological and developmental perspective. , 2005, International review of neurobiology.
[211] P. Hof,et al. Autism: neuropathology, alterations of the GABAergic system, and animal models. , 2005, International review of neurobiology.
[212] M. Graeber,et al. Synaptic stripping in the human facial nucleus , 2004, Acta Neuropathologica.
[213] P. Lazarovici,et al. Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. , 2004, Progress in brain research.
[214] I. Goshen,et al. Impaired interleukin‐1 signaling is associated with deficits in hippocampal memory processes and neural plasticity , 2003, Hippocampus.
[215] C. Gillberg,et al. Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism , 2002, Molecular Psychiatry.
[216] A. McAllister. Neurotrophins and cortical development. , 2002, Results and problems in cell differentiation.
[217] D. Grayson,et al. Reelin gene alleles and susceptibility to autism spectrum disorders , 2002, Molecular Psychiatry.
[218] R Day,et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism , 2002, Molecular Psychiatry.
[219] T. Bourgeron,et al. Linkage and association of the glutamate receptor 6 gene with autism , 2002, Molecular Psychiatry.
[220] J. Licinio,et al. Autoimmunity in autism , 2002, Molecular Psychiatry.
[221] K. Williams,et al. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.
[222] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.
[223] C. McDougle,et al. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. , 2000, Child and adolescent psychiatric clinics of North America.
[224] J. Fryns,et al. The neurobiology of autism. , 1999, Genetic counseling.
[225] R. Duman,et al. Role of 5-HT 2 A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus , 1999 .
[226] B. Juurlink,et al. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. , 1998, The journal of spinal cord medicine.
[227] Martini,et al. Role of , 1995, Physical review. B, Condensed matter.
[228] George M. Anderson,et al. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. , 1993, Life sciences.
[229] E. Cook. Autism: Review of neurochemical investigation , 1990, Synapse.